The companions: Regulatory T cells and gene therapy

Immunology

Volumn 127, Issue 1, 2009, Pages 1-7

  Eghtesad, Saman ^a   Morel, Penelope A ^a   Clemens, Paula R ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene therapy; Muscle immunology disease; Regulatory T cells; Tolerance

Indexed keywords

ADENOVIRUS VECTOR; BLOOD CLOTTING FACTOR 9; CAPSID PROTEIN; DYSTROPHIN; GENE PRODUCT; INTERLEUKIN 2; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ADVERSE OUTCOME; ANTIGEN RECOGNITION; CELL EXPANSION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE MODEL; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE REPLACEMENT THERAPY; GENE THERAPY; GENE TRANSFER; HEMOPHILIA B; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIDE EFFECT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THERAPY EFFECT; TRANSGENE; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

GENE THERAPY; HUMANS; IMMUNE TOLERANCE; MALE; MUSCULAR DYSTROPHY, DUCHENNE; T-LYMPHOCYTES, REGULATORY;

EID: 63849334798     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03069.x     Document Type: Review

References (67)

1. Carl JW Jr., Liu JQ, Joshi PS et al. Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway. J Immunol 2008 181 : 320 8.
2. Tarlinton DM, Batista F, Smith KG. The B-cell response to protein antigens in immunity and transplantation. Transplantation 2008 85 : 1698 704.
3. Chu D, Sullivan CC, Weitzman MD et al. Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors. J Thorac Cardiovasc Surg 2003 126 : 671 9.
4. Jooss K, Yang Y, Fisher KJ, Wilson JM. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 1998 72 : 4212 23.
5. Jooss K, Chirmule N. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther 2003 10 : 955 63.
6. Yuasa K, Yoshimura M, Urasawa N et al. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Ther 2007 14 : 1249 60.
7. Harvey BG, Hackett NR, El-Sawy T et al. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J Virol 1999 73 : 6729 42.
8. Dobrzynski E, Herzog RW. Tolerance induction by viral in vivo gene transfer. Clin Med Res 2005 3 : 234 40.
9. Jerebtsova M, Batshaw ML, Ye X. Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice. Pediatr Res 2002 52 : 95 104.
10. Xiao W, Chirmule N, Schnell MA, Tazelaar J, Hughes JV, Wilson JM. Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther 2000 1 : 323 9.
11. Dobrzynski E, Mingozzi F, Liu YL et al. Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer. Blood 2004 104 : 969 77.
12. Mount JD, Herzog RW, Tillson DM et al. Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 2002 99 : 2670 6.
13. Mingozzi F, High KA. Immune responses to AAV in clinical trials. Curr Gene Ther 2007 7 : 316 24.
14. Jiang Z, Schiedner G, Gilchrist SC, Kochanek S, Clemens PR. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle. Gene Ther 2004 11 : 1453 61.
15. Jiang Z, Schiedner G, van Rooijen N, Liu CC, Kochanek S, Clemens PR. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade. Mol Ther 2004 10 : 688 96.
16. Song L, Wang J, Wang R et al. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? Gene Ther 2004 11 : 1487 96.
17. Wang R, Han G, Wang J et al. Foxp3-expressing CD4(+)T cells under the control of INF-gamma promoter prevent diabetes in NOD mice. Mol Ther 2007 15 : 1551 7.
18. Wang R, Song L, Han G et al. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes. Scand J Immunol 2007 66 : 515 22.
19. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007 7 : 875 88.
20. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000 101 : 455 8.
21. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008 133 : 775 87.
22. Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001 27 : 68 73.
23. Appleby MW, Ramsdell F. Scurfy, the Foxp3 locus, and the molecular basis of peripheral tolerance. Curr Top Microbiol Immunol 2008 321 : 151 68.
24. Del PG. The complexity of the CD4 T-cell responses: old and new T-cell subsets. Parassitologia 2008 50 : 9 16.
25. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004 21 : 589 601.
26. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003 197 : 451 60.
27. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008 8 : 523 32.
28. Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T cells. Immunity 2004 21 : 503 13.
29. Collison LW, Workman CJ, Kuo TT et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450 : 566 9.
30. Stephens LA, Gray D, Anderton SM. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc Natl Acad Sci USA 2005 102 : 17418 23.
31. Chai JG, Xue SA, Coe D et al. Regulatory T cells, derived from naive CD4+. Transplantation 2005 79 : 1310 6.
32. Raimondi G, Turner MS, Thomson AW, Morel PA. Naturally occurring regulatory T cells: recent insights in health and disease. Crit Rev Immunol 2007 27 : 61 95.
33. Seveno C, Coulon F, Haspot F et al. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation. Xenotransplantation 2007 14 : 25 33.
34. Fehervari Z, Sakaguchi S. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int Immunol 2004 16 : 1769 80.
35. Bruder D, Probst-Kepper M, Westendorf AM et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004 34 : 623 30.
36. Glinka Y, Prud'homme GJ. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 2008 84 : 302 10.
37. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 2008 28 : 402 13.
38. Kubach J, Lutter P, Bopp T et al. Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 2007 110 : 1550 8.
39. Wang J, Ioan-Facsinay A, van der Voort EIH, Huizinga TWJ, Toes REM. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007 37 : 129 38.
40. Yamaguchi T, Hirota K, Nagahama K et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 2007 27 : 145 59.
41. Horwitz DA, Zheng SG, Wang J, Gray JD. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur J Immunol 2008 38 : 912 5.
42. Huter EN, Punkosdy GA, Glass DD, Cheng LI, Ward JM, Shevach EM. TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice. Eur J Immunol 2008 38 : 1814 21.
43. Shevach EM, Davidson TS, Huter EN, Dipaolo RA, Andersson J. Role of tgf-Beta in the induction of foxp3 expression and T regulatory cell function. J Clin Immunol 2008 28 : 640 6.
44. Ochando JC, Yopp AC, Yang Y et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol 2005 174 : 6993 7005.
45. Li N, Workman CJ, Martin SM, Vignali DA. Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223). J Immunol 2004 173 : 6806 12.
46. Liang B, Workman C, Lee J et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 2008 180 : 5916 26.
47. Yagi H, Nomura T, Nakamura K et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004 16 : 1643 56.
48. Niedbala W, Wei XQ, Cai B et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007 37 : 3021 9.
49. Ragot T, Opolon P, Perricaudet M. Adenoviral gene delivery. Methods Cell Biol 1997 52 : 229 60.
50. Alba R, Bosch A, Chillon M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther 2005 12 (Suppl. 1 S18 27.
51. Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci USA 1996 93 : 5731 6.
52. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 2008 9 : 632 40.
53. Elpek KG, Yolcu ES, Franke DD, Lacelle C, Schabowsky RH, Shirwan H. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol 2007 179 : 7295 304.
54. Jiang Z, Feingold E, Kochanek S, Clemens PR. Systemic delivery of a high-capacity adenoviral vector expressing mouse CTLA4Ig improves skeletal muscle gene therapy. Mol Ther 2002 6 : 369 76.
55. Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. J Immunol 2005 175 : 6107 16.
56. Pyzik M, Piccirillo CA. The TGF-beta1/Foxp3 regulatory axis in immune self-tolerance: implications for health and disease. Inflamm Allergy Drug Targets 2006 5 : 167 77.
57. Pyzik M, Piccirillo CA. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. J Leukoc Biol 2007 82 : 335 46.
58. Gross DA, Leboeuf M, Gjata B, Danos O, Davoust J. CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. Blood 2003 102 : 4326 8.
59. Spencer MJ, Montecino-Rodriguez E, Dorshkind K, Tidball JG. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol 2001 98 : 235 43.
60. Appel SH. The muscular dystrophies. Clinical update on two major types. Postgrad Med 1978 64 : 93 102.
61. Gilchrist SC, Ontell MP, Kochanek S, Clemens PR. Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector. Mol Ther 2002 6 : 359 68.
62. Bilbao R, Reay DP, Wu E et al. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero. Gene Ther 2005 12 : 39 47.
63. Yang Y, Haecker SE, Su Q, Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 1996 5 : 1703 12.
64. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984 81 : 1189 92.
65. Steinman L. State of the art. Four easy pieces: interconnections between tissue injury, intermediary metabolism, autoimmunity, and chronic degeneration. Proc Am Thorac Soc 2006 3 : 484 6.
66. Farini A, Meregalli M, Belicchi M et al. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. J Pathol 2007 213 : 229 38.
67. David AL, Peebles D. Gene therapy for the fetus: is there a future? Best Pract Res Clin Obstet Gynaecol 2008 22 : 203 18.